Related Experiment Video
Updated: Sep 6, 2025

An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila
Published on: April 15, 2015
Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms
Kenneth Blum1,2,3,4,5, Mark S Brodie6, Subhash C Pandey6
1The Kenneth Blum Behavioral & Neurogenetic Institute, Austin, TX 78701, USA.
Identifying genetic risk factors like KCNK13 and RASGRF2, alongside a genetic addiction risk score (GARS), can help reduce binge alcohol drinking and prevent relapse. This approach offers novel therapeutic and legal strategies for alcohol use disorder.
Area of Science:
- Neurobiology
- Genetics
- Public Health
Background:
- Excessive alcohol consumption, particularly binge drinking, is a significant global public health concern.
- Understanding the neurobiological underpinnings of alcohol use disorder is crucial for developing effective prevention and treatment strategies.
Purpose of the Study:
- To investigate the role of KCNK13 and RASGRF2 genes in alcohol binge drinking.
- To propose a precision medicine approach using genetic addiction risk score (GARS) for pro-dopamine regulation to mitigate alcohol intake.
- To explore the potential application of genetic insights in legal contexts for individuals with alcohol use disorder.
Main Methods:
- Utilized a darkness-induced alcohol intake protocol to study reward pathways and dopamine signaling.
- Examined the function of KCNK13 (potassium two pore domain channel subfamily K member 13) and RASGRF2 (Ras-specific guanine nucleotide-releasing factor 2) genes in relation to alcohol consumption.
- Reviewed existing literature and presented data on the efficacy of GARS-guided interventions in animal models and human cases (drunk drivers).
Main Results:
- Identified KCNK13 and RASGRF2 genes as having significant dopamine-related functions impacting alcohol binge drinking.
- Demonstrated that GARS-guided precision pro-dopamine regulation can reduce alcohol intake and prevent relapse in experimental models.
- Showcased favorable outcomes in reducing alcohol consumption and preventing relapse in binge-drinking animals and individuals apprehended for driving under the influence.
Conclusions:
- Genetic polymorphisms in KCNK13 and RASGRF2, combined with GARS, offer a promising strategy for precision regulation of dopamine signaling to combat binge alcohol drinking.
- The findings support the integration of GARS and genetic risk assessment in therapeutic interventions and potentially in legal defense strategies for alcohol use disorder.
- This research contributes to a better understanding of the neurobiology of addiction and provides a foundation for novel approaches to address polydrug abuse.
More Related Videos
Related Concept Videos
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Depressants: Alcohol and Nicotine
Drug Dependence

